Breathe Well Live Well
Condition: Asthma
Intervention: Drug: Busonid (budesonide 200mcg and 400mcg)
Sponsor: Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting – verified July 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
NDTV |
Blocking A Molecule Can Better Treat Asthma
NDTV The allergic immune response, which triggers the symptoms of asthma, is a complex process, which starts with the over-activation of a certain white blood cell, the allergen-specific helper T cells type 2 that plays an important role in the immune system. Blocking a molecule may help better treat asthma |
View full post on asthma – Google News
Odisha Sun Times |
Blocking a molecule can better treat asthma
Odisha Sun Times The allergic immune response, which triggers the symptoms of asthma, is a complex process, which starts with the over-activation of a certain white blood cell, the allergen-specific helper T cells type 2 that plays an important role in the immune system. Blocking a molecule may help better treat asthma |
View full post on asthma – Google News
KMBC Kansas City |
Northwestern Medicine develops new technology to treat allergies, asthma
Daily Northwestern Northwestern Medicine researchers developed a new technology that can be used to disable food allergies and asthma. The new method includes a biodegradable nanoparticle concealing allergens from the immune system by coating them in a “friendly … Doctor On Demand, Allergy & Asthma Network Team Up To Make Treating Asthma and Allergies Easier for Millions Spring Asthma & Allergy Tips 5 tips to breathe easy this spring |
View full post on asthma – Google News
Medscape |
FDA Approves Cinqair To Treat Severe Asthma
Pharmacy Practice News The FDA has approved reslizumab (Cinqair, Teva Pharmaceuticals) as an add-on maintenance treatment for patients aged 18 years and older with an eosinophilic phenotype asthma, who have a history of severe exacerbations despite receiving their current … FDA approves reslizumab to treat severe asthma Reslizumab (Cinqair) Approved to Treat Severe Asthma Cinqair Receives FDA Approval As Treatment For Severe Asthma |
View full post on asthma – Google News
Medscape |
FDA approves reslizumab to treat severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com FDA has cleared reslizumab (Cinqair—Teva) for use with other asthma medicines for the maintenance treatment of severe asthma in adults. The drug is indicated for patients with a history of severe asthma attacks despite using their current asthma … FDA approves Cinqair to treat severe asthma Reslizumab (Cinqair) Approved to Treat Severe Asthma FDA Approves Teva's Asthma Injection to Treat Severe Asthma |
View full post on asthma – Google News
Medscape |
FDA approves Cinqair to treat severe asthma
FDA.gov The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of … Reslizumab (Cinqair) Approved to Treat Severe Asthma FDA Approves Reslizumab for Adults With Severe Asthma FDA clears Teva's asthma med Cinqair |
View full post on asthma – Google News
Sarasota Herald-Tribune |
Asthma in children is tough to treat
Sarasota Herald-Tribune At their worst, asthma attacks can mean a sudden trip to the emergency room. These can be scary episodes in their own right, but they also disrupt everyday life, interfering with sleep, school or work schedules. Preventing such attacks is a major goal … |
View full post on asthma – Google News
|
University Of Arizona Research Shows Protein Could Help Treat Asthma
KJZZ The federal Centers for Disease Control and Prevention say as of 2012 more than 25 million Americans had asthma. More than 3,600 people died from it that year. Researchers at the University of Arizona are looking to genetics as a possible new treatment. |
View full post on asthma – Google News
|
Medic alleged to have stolen asthma medication to treat her child
EMS1.com Beasley was charged with larceny by an employee and practicing medicine without a license. The practicing medicine charge is for the alleged theft of asthma medication stolen from the 50-210 EMS station and later given by Beasley to her child. |
View full post on asthma – Google News